Cargando…

Neural-ODE for pharmacokinetics modeling and its advantage to alternative machine learning models in predicting new dosing regimens

Forecasting pharmacokinetics (PK) for individual patients is a fundamental problem in clinical pharmacology. One key challenge is that PK models constructed using data from one dosing regimen must predict PK data for different dosing regimen(s). We propose a deep learning approach based on neural or...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, James, Deng, Kaiwen, Zhang, Xinyuan, Liu, Gengbo, Guan, Yuanfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283337/
https://www.ncbi.nlm.nih.gov/pubmed/34308294
http://dx.doi.org/10.1016/j.isci.2021.102804
_version_ 1783723179231936512
author Lu, James
Deng, Kaiwen
Zhang, Xinyuan
Liu, Gengbo
Guan, Yuanfang
author_facet Lu, James
Deng, Kaiwen
Zhang, Xinyuan
Liu, Gengbo
Guan, Yuanfang
author_sort Lu, James
collection PubMed
description Forecasting pharmacokinetics (PK) for individual patients is a fundamental problem in clinical pharmacology. One key challenge is that PK models constructed using data from one dosing regimen must predict PK data for different dosing regimen(s). We propose a deep learning approach based on neural ordinary differential equations (neural-ODE) and tested its generalizability against a variety of alternative models. Specifically, we used the PK data from two different treatment regimens of trastuzumab emtansine. The models performed similarly when the training and the test sets come from the same dosing regimen. However, for predicting a new treatment regimen, the neural-ODE model showed substantially better performance. To date, neural-ODE is the most accurate PK model in predicting untested treatment regimens. This study represents the first time neural-ODE has been applied to PK modeling and the results suggest it is a widely applicable algorithm with the potential to impact future studies.
format Online
Article
Text
id pubmed-8283337
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-82833372021-07-22 Neural-ODE for pharmacokinetics modeling and its advantage to alternative machine learning models in predicting new dosing regimens Lu, James Deng, Kaiwen Zhang, Xinyuan Liu, Gengbo Guan, Yuanfang iScience Article Forecasting pharmacokinetics (PK) for individual patients is a fundamental problem in clinical pharmacology. One key challenge is that PK models constructed using data from one dosing regimen must predict PK data for different dosing regimen(s). We propose a deep learning approach based on neural ordinary differential equations (neural-ODE) and tested its generalizability against a variety of alternative models. Specifically, we used the PK data from two different treatment regimens of trastuzumab emtansine. The models performed similarly when the training and the test sets come from the same dosing regimen. However, for predicting a new treatment regimen, the neural-ODE model showed substantially better performance. To date, neural-ODE is the most accurate PK model in predicting untested treatment regimens. This study represents the first time neural-ODE has been applied to PK modeling and the results suggest it is a widely applicable algorithm with the potential to impact future studies. Elsevier 2021-06-30 /pmc/articles/PMC8283337/ /pubmed/34308294 http://dx.doi.org/10.1016/j.isci.2021.102804 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Lu, James
Deng, Kaiwen
Zhang, Xinyuan
Liu, Gengbo
Guan, Yuanfang
Neural-ODE for pharmacokinetics modeling and its advantage to alternative machine learning models in predicting new dosing regimens
title Neural-ODE for pharmacokinetics modeling and its advantage to alternative machine learning models in predicting new dosing regimens
title_full Neural-ODE for pharmacokinetics modeling and its advantage to alternative machine learning models in predicting new dosing regimens
title_fullStr Neural-ODE for pharmacokinetics modeling and its advantage to alternative machine learning models in predicting new dosing regimens
title_full_unstemmed Neural-ODE for pharmacokinetics modeling and its advantage to alternative machine learning models in predicting new dosing regimens
title_short Neural-ODE for pharmacokinetics modeling and its advantage to alternative machine learning models in predicting new dosing regimens
title_sort neural-ode for pharmacokinetics modeling and its advantage to alternative machine learning models in predicting new dosing regimens
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283337/
https://www.ncbi.nlm.nih.gov/pubmed/34308294
http://dx.doi.org/10.1016/j.isci.2021.102804
work_keys_str_mv AT lujames neuralodeforpharmacokineticsmodelinganditsadvantagetoalternativemachinelearningmodelsinpredictingnewdosingregimens
AT dengkaiwen neuralodeforpharmacokineticsmodelinganditsadvantagetoalternativemachinelearningmodelsinpredictingnewdosingregimens
AT zhangxinyuan neuralodeforpharmacokineticsmodelinganditsadvantagetoalternativemachinelearningmodelsinpredictingnewdosingregimens
AT liugengbo neuralodeforpharmacokineticsmodelinganditsadvantagetoalternativemachinelearningmodelsinpredictingnewdosingregimens
AT guanyuanfang neuralodeforpharmacokineticsmodelinganditsadvantagetoalternativemachinelearningmodelsinpredictingnewdosingregimens